Last updated: 10/11/2024

Best Hospitals for Prostate cancer treatment in Cyprus 2025

Content meets the Bookimed Editorial Policy and is medically reviewed by
Fahad Mawlood - General practitioner. Winner of 4 scientific awards. Served in Western Asia. Former Team Leader of a medical team supporting Arabic-speaking patients. Now responsible for data processing and medical content accuracy.
Best Hospitals for Prostate cancer treatment in Cyprus 2025

Prostate cancer Treatment Overview in Cyprus

Bookimed fees - $0
Doctors - 3
Clinics - 1

What's the Cost of Prostate cancer Diagnostic and Treatment Procedures in Cyprus?

The cost of prostate cancer treatment can range from $8,510 to $17,420:

  • Israel: Robotic da Vinci prostatectomy from $15,000 to $30,000, Prostatectomy from $15,000 to $22,000, NanoKnife from $10,500 to $21,700.
  • Turkey: Robotic da Vinci prostatectomy from $8,000 to $15,000, Hormone therapy from $1,500 to $8,000, Prostatectomy from $4,500 to $16,000, NanoKnife from $5,100 to $9,220.

The doctor will determine the total treatment cost based on your needs and past treatments.

Request the price
Turkey Austria Spain
Brachytherapy from $13003 -from $3793
Prostatectomy from $8500 from $19368 -
Proton-beam therapy from $800 -from $23840
Da Vinci Robotic System from $2500 -from $20589
Robotic da Vinci prostatectomy from $16500 -from $31425
Hormone therapy from $1200 -from $542
NanoKnife from $3000 --
Transurethral resection of the prostate (TURP) from $7500 from $9038 from $1666
Transurethral needle ablation (TUNA) ---
Androgen deprivation therapy ---
Tomotherapy from $10000 -from $7586
HIFU for prostate cancer treatment from $10000 --
Brachytherapy for prostate cancer from $2500 -from $3793
Laparoscopic prostatectomy from $325 -from $17338
Chemotherapy for prostate cancer from $1000 -from $975
Radiotherapy for prostate cancer from $2000 -from $3793
Immunotherapy for prostate cancer from $10000 -from $1084
Hormone therapy for prostate cancer ---
CyberKnife for prostate cancer from $6000 -from $7586
Oncothermia ---
PET/CT from $700 -from $1313
Biopsy from $325 -from $1517
Extended analysis of blood from $50 -from $1084
CT (computer tomography) from $54 -from $325
Scintigraphy from $200 -from $225
Consultation with an oncologist from $100 from $325 from $520
PSA test from $50 --
Histopathology revision from $350 -from $433
Transrectal ultrasound (TRUS) from $180 --
Fusion biopsy from $2200 --
Transrectal ultrasound-guided prostate biopsy from $700 -from $3870
Lab tests from $50 from $249 -
Consultation of a radiologist from $120 -from $580
Comprehensive prostate cancer diagnosis from $2200 -from $2276
CT of the paranasal sinuses from $150 --
MR Linac from $8000 --
The total cost is calculated individually. It may range depending on your medical issue, doctor's qualification, procedure complexity and related complications (if they occur). You’ll get the exact price for a plastic surgery procedure after a consultation with a doctor.
Below average
Above average
According to 1 clinic presented in the ranking
Best Prostate cancer Treatment Centers in Cyprus: 1 Verified Option and Prices
Check the hospital ranking based on requests and 0 reviews to pick the right Prostate cancer clinic for you.

Get a Medical Assessment for Prostate cancer Treatment in Cyprus: Consult with 3 Experienced Doctors Now

Cyprus, Republic of Cyprus
Constantinos Zamboglou
Clinical oncologist
12 years of experience
German Medical Institute
Education09 / 2004 – 07 / 2006                Movie Director School, ANT1 Movie School Athens, Greece, Degree “Television Director”, grade point average: B09 / 2006 – 08 / 2008                Medical School, Semmelweis University Budapest, Hungary, Medical preliminary examination (Physikum), grade point average: A10 / 2008 – 05 / 2013                Medical School, Albert-Ludwigs-Universität Freiburg, Germany, State examination in medicine, grade point average: A02/ 2009 – 02/2012                   Institute of Pharamcology and Toxicology I, Albert-Ludwigs-Universität Freiburg, Germany, Doctoral thesis, grade: summa cum laude05 / 2018                                      Basic and advanced course in German drug law and GCP, Clinical Trials Unit, Medical Center - University of Freiburg01 / 2019                                      Board certification: Radiotherapy and Radiation Oncology03 / 2020                                      Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Habilitation (Postdoctoral lecture qualification)09 / 21 – 08 / 23                         MHBA, Friedrich Alexander University, Nuernberg, Germany07 / 2022                                      Completion of ISO 9001:2015 training, Nicosia, CyprusProfessional Career09 / 2013 – 01 / 2019               Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Residency                                                07 / 2017 – 07 / 2020               Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Clinician ScientistSince 06 / 2019                          Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Consultant01 / 2021 – 12 / 2022                Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Advanced Clinician Scientist01 / 2021 – 12 / 2021                 Head of the section “Interventional Radiation Oncology”, Medical Center University of Freiburg, Department of Radiation Oncology, GermanySince 01 / 2022                         Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Prostate cancer research group leaderSince 01 / 2022                          German Medical Institute, Limassol, Cyprus, Vice Medical DirectorProfessional Memberships and Distinctions2010           Sanofi-Aventis poster prize, Annual meeting of the German Society of Pharmacology and Toxicology 2010, Mainz, Germany      2017           Poster prize, Annual meeting of the German Society of Radiation Oncology (DEGRO) 2017, Berlin, Germany2019           Poster prize, Uro-Oncological Symposium 2019, Magdeburg, Germany2020           Invited member of the German expert panel for prostate cancer of the German Society of Radiation Oncology (DEGRO)2020           Herman-Holthusen Award, German Society of Radiation Oncology (DEGRO)2021           Invited member of the ESTRO-ACROP guideline committee for prostate cancer2021           Best Abstract, EMUC congress 2021, Athens, Greece2023           Annual ARO study price for the HypoFocal-SBRT study from the German Cancer Foundation2023           Invited member of the ESTRO focus group “Urology”
Cyprus, Republic of Cyprus
Konstantinos Ferentinos
Radiation oncologist
12 years of experience
German Medical Institute
Education:  2001-2007: University of Ioannina Medical School, Greece.2007: Degree in Medicine.2013: Doctoral degree from the Medical School of the Johann Wolfgang Goethe University, Frankfurt (Dr. Med)09.2016 – Today: Master’s in Healthcare Business Studies.Professional experience:04.2009 – 04.2013: Resident in the Department for Radiation Oncology, Klinikum Offenbach05.2013 – 12. 2015: Senior physician in the Department for Radiation Oncology, Klinikum Offenbach01.2016 – 06.2017: Senior physician in the Department of interventional Radiation Oncology, Medical Center Athens 07.2017 – Today: Head of the Department of Radiation Oncology at the German Oncology Center, Limassol, Cyprus.
Cyprus, Republic of Cyprus
Petros Tsafrakidis
Urological surgeon
16 years of experience
German Medical Institute
Education/Academic ExperienceApr 1995 – Oct 2001                Medical School of Aristotle University of Thessaloniki, GreeceMar 2007                                   IELTS Certificate (Overall Band Score 7.5)Feb 2011                                    CCST in Urology, Aristotle University of Thessaloniki, GreeceJune 2012                                  Fellow of the European Board of Urology (FEBU)Sept 2014                                  Fellow in Andrology/Reconstructive Surgery (Mr Giulio Garaffa,         UCLH / Mid-Essex)Apr 2016                                   Fellow of the Royal College of Surgeons of England (FRCS Eng)Oct 2018                                   Honorary Senior Lecturer St Andrews UniversitySep 2019                                   Urology ChM Tutor in Andrology and Minimally Invasive Surgery (MIMS) University of EdinburghAug 2020                                  European Union Expert Panel Member of Medical Devices (EU EXPAMED)Current and Previous appointmentsCurrent appointmentMay 2022- Present         Consultant Urologist German Oncology Centre, Limassol, CyprusPrevious appointmentsNov16- May 2021       Consultant Urological Surgeon Victoria/ Queen Margaret Hospital Fife, Scotland.Nov 2012 - Oct 2016      Consultant Urologist Broomfield Hospital, Mid-Essex Hospitals Trust Jan 2011 - Oct 2012      Urology Clinical Research Fellow, Spelialist Registrar Level), Bristol Royal Infirmary, United Bristol Hospitals TrustDec 2009 -Dec 2010      Urology Resident G. Gennimatas Hospital, Aristotle University of ThessalonikiDutiesPerforming routine and major Penile / Urethral Reconstruction as well as Core Urology procedures twice weekly at Victoria and Queen Margaret Hospitals (Green light prostatectomy, Urolift Service lead, Prostate template biopsies, General urology)Consultant Urologist providing and supervising the services of andrology and urethral reconstruction surgery. Also covering a general urology one stop outpatient clinics three times per week (Victoria and Queen Margaret Hospitals).Participation in once weekly local cancer and once monthly specialist male uro-genital reconstruction MDT meetings (Honorary contract at the Western General Hospital, Edinburgh) as well as grand ward rounds.Undergraduate student trainer and member of examiners panel at St Andrews University, Scotland.Participation in 1:9 on call Urology Consultant rota.ResearchVictoria Hospital, Kirkcaldy (NHS Fife) lead investigator. A prospective, multicentre study with subgroup randomisation into MRI-U/S image fusion guided prostate biopsies and routine transrectal U/S guided biopsies.  (MULTIPROS Study) Broomfield Hospital (MEHT) sub-investigator. A pragmatic multicentre randomised superiority trial of open urethroplasty versus endoscopic urethrotomy. (OPEN Study) Broomfield Hospital (MEHT) sub-investigator. A Multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic treatment, for ureteric stones. (TISUStudy) Bristol Royal Infirmary sub-investigator. A Multicentre Randomised Controlled Trial of the Use of Drug Therapy in the Management of Symptomatic Ureteric Stones in Hospitalised Patients. (SUSPEND Study) Bristol Royal Infirmary sub-investigator. A Multicentre Prospective Single Arm Intervention Trial Evaluating Focal Therapy using High Intensity Focused Ultrasound (Sonablate 500) for Localised Prostate Cancer. (HIFU INDEX Study) Bristol Royal Infirmary sub-investigator, A Randomised Controlled Trial to Determine the Effect of Decapeptyl on Reduction of Prostate Volume Pre-Radiotherapy Compared with Standard Therapy (Zoladex). (EDVART Study)Teaching ExperienceFife Simulation BPH Course Fascilitator (Scottish Urology Training Programme, Queen Margaret Hospital, Dumfermline Fife)Urology Simulation boot camp Faculty member (St James's University Hospital, Leeds)General Practitioner Urology Training Programme Fascilitator (ScotGem)Objective Structured Clinical Examination (OSCE) assessor (St Andrews University Medical School)Teaching (case-based discussions) and trainee supervision in theatres (East Anglia / East of   Scotland Deaneries trainees)FY1 Doctors Urology teaching Bristol Royal Infirmary (University Bristol Hospitals Trust)Undergraduate teaching of medical students in General Hospital of the city of Drama, GreeceAnatomy, Physiology and First Aid to Undergraduate nursing students
This page may feature information relating to various medical conditions, treatments, and healthcare services available in different countries. Please be advised that the content is provided for informational purposes only and should not be construed as medical advice or guidance. Please consult with your doctor or a qualified medical professional before starting or changing medical treatment.

Bookimed editorial policy

Bookimed, a leading global medical tourism platform, is committed to helping clients looking for Prostate cancer treatment by offering expert assistance and trustworthy medical solutions for every situation. Smart automatic ranking system is used to compose transparent clinic listings, meticulously maintained by a data scientist using AI for accuracy. The platform guarantees authenticity by publishing reviews from real patients after their treatments. Bookimed offers comprehensive medical solutions, with updates from clinics to ensure trustworthiness. The content about Prostate cancer treatment, crafted by experienced medical authors and reviewed by specialists, adheres to Bookimed"s Editorial Guidelines, reflecting the platform"s commitment to delivering high-quality and clear health information. For more details or inquiries, feel free to contact us at marketing@bookimed.com or learn more about us and our mission here.